Vitamin B4 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal Feed, Food Industry, Pharmaceutical, Others), By Region & Competition, 2021-2031F

The Global Vitamin B4 Market is projected to grow from USD 789.02 Million in 2025 to USD 1005.87 Million by 2031, exhibiting a 4.13% CAGR. Chemically identified as adenine, Vitamin B4 is a crucial purine nucleobase essential for protein synthesis and cellular energy transfer, acting as a core component of DNA, RNA, and ATP. Its market is primarily driven by demand from the expanding pharmaceutical sector for high-purity adenine in antiviral and immunosuppressive therapies, and from the animal nutrition industry, where it serves as a feed additive to enhance livestock immunity and growth. These applications stem from specific industrial and medicinal requirements for efficient metabolic function in humans and animals, rather than general wellness trends.\n\nHowever, the market's expansion faces a significant challenge due to volatile raw material costs and complex supply chains, which cause pricing instability for both manufacturers and end-users. Despite this, robust downstream consumption is evident; for example, industrial feed production in China increased by 7.7 percent in the first half of 2025 compared to the previous year, according to the China Feed Industry Association. While this data confirms strong demand, the unpredictable nature of input expenses continues to impede consistent market growth.

Market Driver

A dominant force in the global Vitamin B4 market is its increasing utilization in animal feed additives for livestock health. As a vital purine nucleobase, adenine is progressively integrated into feed premixes to strengthen immune function and optimize metabolic energy transfer in poultry and swine, directly addressing the industry's need for efficient protein conversion. This demand is further amplified by the recovery in global livestock production, necessitating greater volumes of fortified feed to meet yield targets; Alltech reported a 1.2% increase in global feed production to 1.396 billion metric tons in 2024. Supporting this trend, China's total red meat and poultry production reached 96.63 million tons in the preceding year, underscoring the sustained requirement for livestock sustenance.\n\nThe expansion of pharmaceutical applications and therapeutic formulations constitutes the second critical market driver, leveraging adenine's role as a precursor for antiviral drugs and immunosuppressive agents. Manufacturers prioritize high-purity Vitamin B4 grades to adhere to stringent biopharmaceutical standards, particularly for nucleoside analog synthesis vital in treating viral infections and chronic diseases. This strategic shift towards specialized medicinal use is reflected in the financial performance of contract development and manufacturing organizations; Lonza's Small Molecules division, for instance, reported a 9.3% sales growth in 2024, driven by high commercial demand for complex active pharmaceutical ingredients.

Market Challenge

The primary impediment to the stability and growth of the Global Vitamin B4 Market is the volatility of raw material costs and the complexities inherent in supply chains. Manufacturers of Vitamin B4 are heavily dependent on a consistent supply of chemical precursors and energy-intensive synthesis processes to produce high-purity adenine. Unpredictable fluctuations in upstream input costs make it difficult for producers to maintain stable pricing structures, thereby hindering their ability to secure long-term contracts with key downstream buyers in the pharmaceutical and animal nutrition sectors. This economic uncertainty often compels manufacturers to accept reduced margins or pass increased costs onto end-users, frequently resulting in delayed procurement decisions and diminished market liquidity.\n\nThe broader chemical manufacturing sector, which underpins adenine production, illustrates the profound impact of these cost pressures. In 2025, the European Chemical Industry Council reported a drop in capacity utilization to 74.6 percent, as producers contended with energy and feedstock expenses that remained three times higher than those in competitive regions like the United States. Such consistently high and unstable operational expenditures deter crucial investments in production capacity and innovation, consequently obstructing the overall growth trajectory of the Vitamin B4 market.

Market Trends

A fundamental shift in Vitamin B4 manufacturing involves the transition toward sustainable enzymatic synthesis methods, driven by the imperative to reduce the environmental footprint and energy consumption associated with traditional chemical processes. Producers are increasingly adopting biocatalytic systems over conventional chemical catalysis, as these offer enhanced specificity and generate less hazardous waste, which is crucial for complying with strict environmental regulations in major production areas. This industrial change is supported by the robust financial performance of leading biosolution providers, such as Novonesis, which reported an 8% organic sales growth in 2024, highlighting the accelerating industry adoption of biological manufacturing technologies over older chemical methods.\n\nConcurrently, the market is observing a distinct expansion into abiotic stress-resilient plant biostimulants, where adenine is employed to improve crop tolerance against adverse environmental conditions like drought and salinity. This trend, distinct from conventional fertilizer applications, focuses on modifying plant physiological pathways to ensure yield stability, thereby carving out a high-value niche for Vitamin B4 beyond its traditional role in animal nutrition. The increasing reliance on advanced agricultural biologicals is evident in the sales volumes of major agriscience corporations; Corteva Agriscience, for instance, reported a 7% increase in crop protection sales volume during the first nine months of 2025, a growth largely attributed to the rising global demand for new biological formulations and stress-management products.

Key Market Players

• Shandong Yinfeng Biological Technology Co., Ltd.
• GHW International
• St. Gabriel CC Company, LLC
• Balchem Corporation
• Jubilant Ingrevia Limited
• Hangzhou Donglou Bio-Nutrition Co., Ltd.
• Shandong NB Technology Co Ltd.,
• Shandong Jujia Biotech Co.,Ltd
• Liaoning Biochem Co., Ltd
• Shandong Aocter Chemical Co.,Ltd.

Report Scope

In this report, the Global Vitamin B4 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B4 Market, By Sales Channel

• Direct
• Indirect

Vitamin B4 Market, By End Use

• Animal Feed
• Food Industry
• Pharmaceutical
• Others

Vitamin B4 Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B4 Market.

Available Customizations:

Global Vitamin B4 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).